NEUPROGRAMMIERUNG VON KREBSZELLEN

European patent · EP3524672 · Deleted

Register entry

Publication number
EP3524672
Application number
EP19165472
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jun 16, 2011
Published
Aug 14, 2019
Granted
May 28, 2025
Deleted
Jan 27, 2026
Reason
Annual fee unpaid
IPC classes
C12N 5/0735 (2010.01)
C12N 5/074 (2010.01)
C12N 5/095 (2010.01)
G01N 33/569 (2006.01)
Priority
US 35548310 P 16.06.2010
US 38565310 P 23.09.2010
US 201061428360 P 30.12.2010
US 201161453917 P 17.03.2011
US 201161472516 P 06.04.2011
US 201161474236 P 11.04.2011
US 201161484052 P 09.05.2011
Divided from
EP11796473
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 9, 2026

    Change

    Published in Swissreg on 09.04.2026

  2. Jan 27, 2026

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    27.01.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 27.01.2026

  3. May 28, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 28.05.2025

Parties

Holder

Minerva Biotechnologies Corporation

40 Bear Hill Rd., Waltham, MA 02451, US

Inventor

BAMDAD, Cynthia

Boston, MA 02115, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.